What are the concerns of ranitidine and breastfeeding?

Rannitidine is a medicine that is often recommended for those suffering from stomach problems such as heartburn. Since 2011, the side effects have been reported rare, but potential effects on newborn or very young children have not been expanded. Mothers of ranitidine and breastfeeding may not be a suitable mixture, especially because it is known that the drug passes into breast milk. Advice on how to avoid its use during breastfeeding is not based on a specific evidence of the child's damage, but rather on the basis of the drug may have effects that have not yet been identified.

Infants are fragile creatures as they are still evolving, thus more vulnerable than other people to drug effects. Pregnancy drugs tend to be carefully monitored and breastfeeding mothers can be discouraged from taking certain drugs. If the child is breastfeeding, the mother may pass the substances to him or it through breast milk and potentially endanger the child. As for ranitidine auctioned that breastfeeding, ranitidine enters breast milk and therefore may bet its use for the mother and the child risky.

Clinical drug studies usually focus on the effects of adult volunteers. Children, pregnant women and children are usually not used for research for ethical reasons. For many drugs, evidence of safety during pregnancy or breastfeeding tends to be incomplete. Sometimes, extensive information about the possible effects of medicine can be obtained from individual patients taking a medicine outside clinical studies, but this is not true for exploring ranitidine and breastfeeding.

isolated incidence of ranitidine and breastfeeding have been reported in medical literature and these cases seem to show that ranitidine has no adverse effect on breastfeeding. Animal studies have not shown that the drug has no adverse effects on fruits during pregnancy. Some women receive a medicine during childbirth to prevent the state called Mendelsohn's syndrome, and it seems that the drug does not cause a childa stare adverse effect.

In some children, a state called tension ulcer may develop, and ranitidine is often used to prevent this from developing. When the drug is given to newborn children, at a level five times higher than it is usually found in breast milk, it has no bad effects. Since 2011, a drug called cimetidine, which is similar to ranitidine, has been approved by some medical offices for the use of breastfeeding. Despite the availability of a small amount of information that seems to show that ranitidin is safe for use in this situation, lack of research means that women have to balance the benefits of the drug against the theoretical possibility of damage to the child.